COMPANY NEWS - NEWS - 尊龙凯时生物

News & Events

PRESS RELEASE

Scroll down

News & Events

WITNESSING OUR DEVELOPMENT

2024-04-01

Hasten and Naxions Signed a Strategic Cooperation Agreement on the "Hasten&Naxions Innovation Project"

On 29th, March, Hasten Biopharmaceutical Co., Ltd (hereinafter referred to as "Hasten") signed a strategic cooperation agreement with Naxions on the "Hasten&Naxions Innovation Project". According to the agreement, Naxions will assist in promoting the accessibility of Hasten's high-quality products in specific markets through its multi-dimensional digital model to benefit more patients and jointly create greater social health value.
FIND OUT MORE
2023-12-25

Hasten Signed MOU with CR Gosun for Deep Collaboration

On December 19, 2023, Hasten’s CEO Summer XIA, Vice President and Head of Commercial Excellence Hanson Zheng and other senior leaders from Hasten visited Shenzhen China Resources Gosun Pharmaceutical Co., Ltd. (CR Gosun), and signed a MOU for the deep collaboration with CR Gosun.
FIND OUT MORE
2023-12-18

Hasten and Apeloa to Start a Strategic Business Cooperation

On December 14, 2023, Hasten Biopharmaceutical Co., Ltd announced that it will enter into a strategic business partnership with Apeloa Pharmaceutical Co., Ltd.
FIND OUT MORE
2023-12-11

ESG Practitioner | Hasten Receives 2023 Avon China's Best Employer ESG Seed Award

December 8th, 2023 – Shanghai, China. Avon Group, a leading global professional services firm, today announced it has released the China Best ESG Employers Award list for 2023 and another eight earning individual awards for outstanding performance in their specific fields. Hasten Biopharmaceutical Company Limited (Hasten) was awarded " 2023 China's Best Employer ESG Seed Award" for the energy and great potential of company’s organizational optimization and agile operation model.
FIND OUT MORE
2023-11-20

Hasten Signs Strategic Cooperation Agreement with China Resources（Shanghai）on CIIE 2023

Hasten Biopharmaceutical Co., Ltd. (Hasten) and China Resources Pharmaceutical Commercial Group (Shanghai) Co., Ltd. reached a strategic cooperation at the 6th CIIE on November 7th of 2023.
FIND OUT MORE
2023-11-10

声明

近日，尊龙凯时生物医药有限公司获悉有不法分子假冒我司名义发布招聘信息、邀请面试以及给求职人员发送虚假录用通知函等行为，严重侵害了我司和广大应聘者的合法权益。为防止应聘者的切身利益受到损害，维护我司的声誉，我公司现郑重声明如下：
FIND OUT MORE

<1 2 3 4 >

HEFEI BEIJING SHANGHAI GUANGZHOU HANGZHOU

No.99, Shanshui Road, Dianbu Town, Feidong County, Hefei, Anhui, China

Eberson Pharmaceuticals Co., Ltd.

No.69, Shanshui Road, Dianbu Town, Feidong County, Hefei, Anhui, China

601-603/6F, Fortune Financial Center 5 Dong San Huan Central Road Chaoyang District, Beijing, China

22nd Floor, New Bund Shun Tak Center No. 18, Lane 666, Hai Yang West Road, Pudong New Area, SHANGHAI 200026

Room 3301-3302, China International Center Tower B, No. 33 Zhongshan Third Road Yuexiu, Guangzhou, China

20th Floor, #G Build, Huanglong International Center Tower, No.77, Xueyuan Road, West Lake District, Hangzhou, Zhejiang, China

Guidelines for Reporting Adverse Drug Reactions

HONG KONG

GERMANY

BEIJING

SHANGHAI

SWITZERLAND

HEFEI

GUANGZHOU

Disclaimer | Privacy | Terms of Use